Cannabis Law Report

DECEMBER 27, 2019

Virtual Clinical Trials transcend geographic, mobility and economic barriers. Clinical trials are medical research projects involving human participants. However, the costs of conducting a full-scale clinical trial can be prohibitive, posing barriers to research for cannabis companies.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

NORML

APRIL 30, 2020

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management.

Chronic Pain 341

Chronic Pain Clinical Trials Data Patients 341

NORML

MARCH 30, 2020

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings.

CBD 295

CBD Clinical Trials Data Treatment 295

Cannabis Law Report

JUNE 2, 2021

Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. Department of Veteran Affairs’ most recent data. None of it was initially slated to go to clinical trials. Between Dec. Read more at.

Clinical Trials 105

Clinical Trials Marijuana Recreational Collective 105

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 193

Clinical Trials Chronic Pain Data Treatment 193

Veriheal

FEBRUARY 9, 2023

A fascinating new clinical trial demonstrates how this psychedelic compound could make people significantly more comfortable while undergoing MRIs or similar procedures. All imaging and behavioral data will be accessible to the public after the study is complete. What Is an MRI?

Clinical Trials 98

Clinical Trials Research and Development Data Collective 98

Veriheal

JUNE 30, 2023

For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

MAY 14, 2022

One of the largest and arguably sustainable customer bases, however, is consumers with some sort of health or therapeutic need for which they are unable to access medicinal cannabis. One potential consequence of the FSA’s drive to rein in the UK’s CBD industry is reduced access to the previously available wide range of products.

Access 52

Access CBD Research and Development Medicine 52

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. Guy Goodwin appointed Chief Medical Officer and Danielle Schlosser appointed Senior Vice-President, Clinical Innovation. On track to report top-line data by end of 2021.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

MAY 10, 2022

Data obtained through a freedom of information request to drugs regulator the Therapeutic Goods Administration (TGA) revealed the age of those prescribed the drugs, the reason for prescribing, and the state or territory where the prescription was made. We are aware of clinical trials in that space, but not strong evidence.”.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

AUGUST 17, 2021

Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

NOVEMBER 23, 2021

London, UK – 23 November 2021 COMPASS Pathways plc a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it has been granted its fifth patent by the US Patent and Trademark Office. PRESS RELEASE. ” About COMPASS Pathways.

Clinical Trials 52

Clinical Trials Therapy Research and Development Media 52

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. The authors note, however, that the data doesn’t include patient outcomes. Here’s the Uni of Sydney press release. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Veriheal

MAY 26, 2022

RoC also works to increase patients’ access to medical cannabis by helping U.S. Of course, legalization and education efforts can only go so far without data, and that’s where RoC’s research initiatives come into play. To date, Veriheal’s global team has helped hundreds of thousands of patients gain access to medical cannabis.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Veriheal

MAY 3, 2022

Kevin Potter taking responsibility for the integrity and accuracy of the data. a necessary question to address as medical marijuana becomes more accessible. The outcomes and measures used throughout the trial included changes in CUD symptoms; anxiety and depressive symptoms; pain severity; and insomnia symptoms.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

SpeedWeed

SEPTEMBER 17, 2021

Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. The millions of people afflicted with PTSD may soon have access to MDMA therapy, and we believe the millions suffering from TBI may experience similar relief in the future.”.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

The Joint Blog

FEBRUARY 11, 2022

The data from this study is promising and reveals that CBD worked to inhibit the spread of a virus in human lung cell samples, which is huge news. However, it warrants further examination and exploration by science in the form of clinical trials, which is what many in the scientific community are calling for.

Clinical Trials 49

Clinical Trials CBD Conditions Data 49

Cannabis Law Report

JANUARY 31, 2022

This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. Earlier this month, Health Canada added certain psychedelic compounds to the SAP that were previously available only through clinical trials. investment community.”

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Cannabis Law Report

SEPTEMBER 12, 2022

The Company is working to supply various upcoming phase 1 & 2 clinical trials to build out the required human safety data in healthy Canadians, and eventually patients suffering from depression, anxiety, and PTSD. To access a complete photo gallery of this historic grow, please click here. Penis Envy. Blue Pulaski.

History 52

History Clinical Trials Legalization Research and Development 52

Cannabis Law Report

JULY 28, 2021

MAPS PBC strives to continually improve upon the supportive, equitable and accessible work environment. QC study data output files and raw datasets into data tables for regulatory documents as needed. 2-3 years of relevant experience in clinical trials, research methods, or statistical design and analysis.

Clinical Trials 105

Clinical Trials Research and Development Data Environment 105

The Cannigma

FEBRUARY 2, 2021

Patients can also access CBD products without a prescription through local pharmacies. Our data confirm that PD patients have a high interest in treatment with medicinal cannabis but lacked knowledge about how to take it and especially the differences between the two main cannabinoids, THC and CBD,” said Buhmann.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

MAY 29, 2022

Approval of providing the psychedelic compound that comes from magic mushrooms started after Health Canada launched a program in January that allows physicians to request government approval for patients to access psilocybin. And there are literally hundreds of trials that are being done, and more forthcoming.”.

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

Cannabis Law Report

JANUARY 12, 2022

Through this collaboration, the NPA and Maya will offer both the education and the technology infrastructure needed to make this possible, ensuring accessibility and safety to all communities. “We NPA’s mission is to ensure all Americans get the support they need to safely access psychedelic-assisted care.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

SEPTEMBER 14, 2021

This alliance is just the first step in a larger movement to co-create a future where consumers have access to trusted cannabinoid products that fully deliver on their potential to help people live healthier, fuller lives.”. Step five: The OBX and Radicle Science validated product is sent to production.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Cannabis Law Report

NOVEMBER 22, 2019

. “As MMJ International Holdings continues to advance to its clinical trials, a specialty pharmaceutical solutions company will be supporting MMJ with the FDA, DEA required development API and specialized liquid encapsulation solutions,” said Elio Mariani, PhD, EVP of Research & Development.

DEA 66

DEA Clinical Trials THC Research and Development 66

The Cannigma

JUNE 14, 2021

‘Junk’ cannabis ‘ill-suited for clinical trials’. The cannabis grown at the University of Mississippi “is junk, ill-suited for clinical trials, and genetically closer to hemp than the marijuana available from dispensaries and used by Americans nationwide,” according to the lawsuit.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

SpeedWeed

MAY 22, 2021

The US Food and Drug Administration (FDA) has just approved a new clinical trial that will allow therapists to legally use MDMA. For this Phase 1 trial, MAPS will recruit 150 therapists that are currently being trained to conduct MDMA-assisted therapy sessions for PTSD. .

Clinical Trials 52

Clinical Trials Therapy Legalization Research and Development 52

Project CBD

AUGUST 6, 2019

Over 200 scientists from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpiblished data. Results highlight the need for expanded patient access to CBD products.”. CBD for hypertension.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Cannabis Law Report

FEBRUARY 5, 2022

Support new product development and further clinical activities. Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

DECEMBER 15, 2021

Support new product development and further clinical activities. Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Veriheal

MARCH 23, 2023

The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. Data suggests that the market has inflated from JPY4 billion (USD$3 billion) in 2019 to JPY17 billion (USD$13 billion) in 2022.

Legalization 81

Legalization Marijuana Clinical Trials Seed-To-Sale 81

Cannabis Law Report

SEPTEMBER 20, 2021

provides Heritage and subsidiary Opticann the benefits of offering patients access to safe, convenient, and effective CB4 products developed on trusted technology platforms. TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable and accessible work environment. Key Responsibilities. Position Requirements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Project CBD

AUGUST 6, 2019

Just over 500 participants from around the world attended the four-day conference, which included 65 oral presentations and nearly 200 posters covering a wide range of topics – with the caveat that researchers had to present new, unpublished data. Results highlight the need for expanded patient access to CBD products.”.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Cannabis Law Report

JULY 30, 2019

This unprecedented proposal is contained in the government’s consultation document on giving greater access to medicinal cannabis. The key driver for this seems to be that people currently access cannabis through the illegal recreational market. From trial to market. Finally, the medicine moves into “efficacy” trials.

Medicine 40

Medicine Clinical Trials Safety Access 40

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. This means that U.S. Drug Enforcement Agency (DEA).

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104